痴呆症每日时间管理:与痴呆症患者及其亲属进行定性访谈
Ann-Christine Persson1,2, Lena Dahlberg3,4, Gunnel Janeslätt5,6
1Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden. ann-christine.persson@ki.se.
BMC geriatrics
|July 3, 2023
概括
其他重要的人提供关键的日常时间管理支持为痴呆症患者,即使有时间辅助技术 (AT). 时间AT有助于定位和共享管理,但不给予独立性.
科学领域:
- 老年学是指老年学的学科.
- 人与计算机的交互
- 痴呆症护理 痴呆症护理 痴呆症护理
背景情况:
- 痴呆症患者经历了与时间相关的挑战,需要在日常时间管理中得到其他重要人的支持.
- 时间辅助技术 (AT) 的使用越来越多,但它对照顾者的影响和痴呆症患者的经验需要进一步探索.
- 现有的关于痴呆症患者时间AT的定性研究是有限的.
研究的目的:
- 探索轻度至中度痴呆症患者及其亲属的日常时间管理经验.
- 了解时间AT如何影响痴呆症患者的日常生活及其支持网络的看法.
主要方法:
- 使用半结构面试对痴呆症患者 (n=6) 和他们的重要其他人 (n=9) 进行定性研究.
- 面试是在处方时间AT后三个月进行的.
- 数据分析使用了定性内容分析.
主要成果:
- 其他重要的人在所有痴呆症阶段都为日常时间管理提供持续支持,通常与其他形式的协助相结合.
- 时间管理支持的需要在痴呆症的早期出现,责任逐渐转移到重要的人.
- 时间AT有助于时间导向和共享管理,但不促进痴呆症患者的独立时间管理.
结论:
- 早期的时间相关评估和干预对于维护痴呆症患者日常时间管理技能至关重要.
- 时间AT可以通过改善时间沟通来增强痴呆症患者的行动和参与能力.
- 对于痴呆症患者而言,社会支持至关重要,因为他们缺乏管理时间的重要他人支持.
相关概念视频
01:30Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
01:26Methods of Documentation II: POMR
998
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
998
01:26Methods of Documentation IV: Focus Charting
1.1K
Focus Charting, also known as the focus charting system or "focus documentation," is a systematic documentation approach used in healthcare to organize patient information in medical records.
It typically involves three columns for recording information:
It typically involves three columns for recording information:
1.1K
01:22Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
01:29Nursing Assessment
7.7K
The two sources for collecting information are primary and secondary. After gathering information, interpretation and validation help to complete the data. The purpose of assessment is to establish data with the initial information, to interpret data about the patient's perceived needs and health problems, and to respond to these problems identified.
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
7.7K
01:26Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527